Expertise in
29
conditions

Dr. Brock P. Whittenberger

Oncology
Billings Clinic
801 N 29th St, 
Billings, MT 
Expertise in
29
conditions
Billings Clinic
801 N 29th St, 
Billings, MT 

Overview

Brock Whittenberger is an Oncologist practicing medicine in Billings, Montana.

Dr. Whittenberger is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Colorectal Cancer, Familial Colorectal Cancer, and Chronic B-Cell Leukemia (CBCL).

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 3 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in MT

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Billings Clinic
801 N 29th St, Billings, MT 59101

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
monarcHER: A Phase 2, Randomized, Multicenter, 3-Arm, Open-Label Study to Compare the Efficacy of Abemaciclib Plus Trastuzumab With or Without Fulvestrant to Standard-of-Care Chemotherapy of Physician's Choice Plus Trastuzumab in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
monarcHER: A Phase 2, Randomized, Multicenter, 3-Arm, Open-Label Study to Compare the Efficacy of Abemaciclib Plus Trastuzumab With or Without Fulvestrant to Standard-of-Care Chemotherapy of Physician's Choice Plus Trastuzumab in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
Enrollment Status: Completed
Publish Date: November 26, 2024
Intervention Type: Drug
Study Drugs: Abemaciclib, Trastuzumab, Fulvestrant, Standard of Care Single Agent Chemotherapy
Study Phase: Phase 2
A Phase 2 Study of Brentuximab Vedotin in Combination With Standard of Care Treatment (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone [RCHOP]) or RCHP (Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone) as Front-line Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
A Phase 2 Study of Brentuximab Vedotin in Combination With Standard of Care Treatment (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone [RCHOP]) or RCHP (Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone) as Front-line Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment Status: Terminated
Publish Date: June 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

1 Total Publications

High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis.
High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis.
Journal: Physical biology
Published: February 07, 2012
Similar Doctors
Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

Billings Clinic

801 N 29th St, 
Billings, MT 
 (0.1 miles away)
406-238-2500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Justin Bottsford-Miller is an Oncologist practicing medicine in Billings, Montana. Dr. Bottsford-Miller is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, and Hernia Surgery. Dr. Bottsford-Miller is currently accepting new patients.

Expertise in
17
conditions
Dr. Megan M. Petersen
Oncology | Obstetrics and Gynecology
Expertise in
17
conditions
Dr. Megan M. Petersen
Oncology | Obstetrics and Gynecology
Referral may be required
Before you request

St. Vincent Regional Hospital - Cancer Centers Of Montana

1315 Golden Valley Circle, 
Billings, MT 
 (4.1 miles away)
406-238-6290
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Petersen was born and raised in Arvada, Colorado. She earned her undergraduate degree from the University of Colorado - Boulder and her Doctor of Medicine from the University of Colorado Health Sciences Center in Denver. Dr. Petersen completed an Internal Medicine Internship with the University of Utah – Salt Lake City and an Obstetrics and Gynecology Residency with Banner Good Samaritan Medical Center in Phoenix, Arizona. She completed a Gynecologic Oncology Fellowship with the University of California, Davis Medical Center. A board-certified provider, Dr. Petersen’s clinical interests include treating and preventing cervical, endometrial, ovarian, vaginal, and vulvar cancers, targeted treatments, minimally invasive surgery, complementary and alternative medicine incorporation into Western Medicine, and holistic oncology care.“I will be with you during the hard times and celebrate the successes. You will be cared for. I am passionate about shared decision-making. Empowering you with as much information as you would like and any additional information I think you should know. I believe in Individualized patient care and listening to what my patients need.”When not in the office, Dr. Petersen enjoys spending her time in the mountains with her family. Dr. Petersen is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Ovarian Carcinosarcoma, Colonoscopy, and Bladder Reconstruction. Dr. Petersen is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Petersen is currently accepting new patients.

Expertise in
33
conditions
Expertise in
33
conditions
Referral may be required
Before you request

St. Vincent Regional Hospital - Cancer Centers Of Montana

1315 Golden Valley Circle, 
Billings, MT 
 (4.1 miles away)
406-238-6290
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Christianson is an investigator involved in clinical research trials in the area of medical oncology and hematology. Dr. Christianson is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Breast Cancer in Men, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Christianson is board certified in American Board Of Internal Medicine. Dr. Christianson is currently accepting new patients.

Frequently Asked Questions about Dr. Brock P. Whittenberger

How do I make an appointment with Dr. Brock P. Whittenberger?

You can book an appointment with Dr. Brock P. Whittenberger by calling their office at 406-238-2500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Brock P. Whittenberger a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Brock P. Whittenberger is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Brock P. Whittenberger specialize in?

While Dr. Brock P. Whittenberger is a Oncology, they have specific expertise in Multiple Myeloma, Colorectal Cancer, and Familial Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Brock P. Whittenberger participate in research or clinical trials?

Yes. Dr. Brock P. Whittenberger has published 1 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Brock P. Whittenberger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Brock P. Whittenberger accept my insurance?

Dr. Brock P. Whittenberger accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly at 406-238-2500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Whittenberger's expertise for a condition
ConditionClose
    View All 28 Advanced Conditions
    View All 94 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile